Montreal, Quebec--(Newsfile Corp. - April 8, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

A groundbreaking study has revealed that a simple at-home saliva test can more accurately detect aggressive prostate cancer than the standard prostate specific antigen (PSA) blood test. The saliva ...

The issuer is solely responsible for the content of this announcement.

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

With an arsenal of antibody assets based on IgE, IgA, and IgG, the newly combined company has opportunities across cancer indications.

Cardinal is using its own cyclotron installations to produce Gozellix for distribution across a range of US locations.

According to the latest research, four out of ten men die from prostate cancer. Oakwood University Church wants to inform and engage as many as possible to counter those numbers.

Promising results of a study on an at-home saliva test could 'turn the tide on prostate cancer', say experts. Read more.

WITH an impressive attendance of 20,522 participants from 131 countries, the European Congress of Radiology (ECR) 2025 was an ...

Researchers say findings provide compelling evidence underscoring the potential of electric-field molecular fingerprinting for minimally invasive disease detection.